Risk Assessment of Prostatic Pathology in Patients Undergoing Radical Cystoprostatectomy
Joseph A. Pettus(Memorial Sloan Kettering Cancer Center), Bernard H. Bochner(Memorial Sloan Kettering Cancer Center), Guido Dalbagni(Memorial Sloan Kettering Cancer Center), Hikmat Al‐Ahmadie(Unknown), S. Machele Donat(Memorial Sloan Kettering Cancer Center), Semra Olgac(Memorial Sloan Kettering Cancer Center), Daniel A. Barocas(Vanderbilt University Medical Center), Theresa M. Koppie(Memorial Sloan Kettering Cancer Center), Harry W. Herr(Memorial Sloan Kettering Cancer Center), Victor E. Reuter(Memorial Sloan Kettering Cancer Center)
Cited by 104
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|867